ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1499

Detection Of CD4+CD25lowGITR+ T Lymphocytes In Sjogren’s Syndrome-Interstitial Lung Disease

Wu Zhenbiao1 and Chen Lina2, 1Clinical Immunology, First Affiliated Hospital, Fourth Military Medical University, Xi'An, China, 2Clinical Immunology, First Affiliated Hospital, Fourth Military Medical University, Xi‘an, China

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: pulmonary complications and regulatory cells, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Title: Sjögren's Syndrome: Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

CD4+CD25lowGITR+ T lymphocytes expressing FoxP3 and showing regulatory function have been recently described in healthy donors (HD). The objective of this study was to determine whether CD4+CD25lowGITR+ T lymphocytes are detected in peripheral blood (PB) and broncho-alveolar lavage (BAL), to investigate their in patients with interstitial lung disease (ILD) secondary to primary Sjogren’s syndrome (pSS).

Methods:

CD4+CD25lowGITR+ cells circulating in PB and BAL of patients with pSS-ILD were isolated by MACS technique, and their phenotype was studied by flow cytometry and real-time PCR, and their function was studied by in vitro co-culture. CD4+CD25lowGITR+ cells infiltrating salivary glands (SGs) were revealed by immunohistochemistry.

Results: Nineteen patients with idiopathic pulmonary fibrosis (IPF) and 13 patents with pSS-ILD were enrolled in the study. Ten healthy donors were concluded in the study, too. Results indicated that conventional CD4+CD25high regulatory T cells (Tregs) are decreased, whereas CD4+CD25lowGITR+ cells are expanded in the PB of pSS-ILD as compared with HD and IPF. Phenotypic analysis demonstrated that CD4+CD25lowGITR+ cells display Treg markers, including FoxP3, TGF-β and IL-10, and functional experiments demonstrated that they exert a strong inhibitory activity against autologous effector cells. The number of CD4+CD25lowGITR+ cells infiltrating in the SG were positively correlated with the inflammatory infiltrating of CD4+CD25lowGITR+ cells in BAL.

Conclusion:

The present data demonstrate that CD4+CD25lowGITR+ cells are detectable in PB and BAL of pSS-ILD patients. These cells, displaying Treg phenotype and function, are present in SG inflamed tissues and are in accordance with that infiltrating in BAL.


Disclosure:

W. Zhenbiao,
None;

C. Lina,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detection-of-cd4cd25lowgitr-t-lymphocytes-in-sjogrens-syndrome-interstitial-lung-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology